D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
FDMT holding history
4D Molecular Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FDMT overviewAll 13F holders of FDMTFull Q2 2026 holdings
- Shares (Q2 2026)
- 44,354
- Value
- $589.9K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 44,354 | $589.9K | <0.1% | +20,324+84.6% | Added | Holders |
| Q1 2026 | 24,030 | $223.7K | <0.1% | −87,792−78.5% | Reduced | Holders |
| Q4 2025 | 111,822 | $838.7K | <0.1% | +101,722+1,007.1% | Added | Holders |
| Q3 2025 | 10,100 | $87.8K | <0.1% | −11,035−52.2% | Reduced | Holders |
| Q2 2025 | 21,135 | $78.4K | <0.1% | −4,205−16.6% | Reduced | Holders |
| Q1 2025 | 25,340 | $81.8K | <0.1% | −10,693−29.7% | Reduced | Holders |
| Q4 2024 | 36,033 | $200.7K | <0.1% | −3,117−8.0% | Reduced | Holders |
| Q3 2024 | 39,150 | $423.2K | <0.1% | −4,276−9.8% | Reduced | Holders |
| Q2 2024 | 43,426 | $911.5K | <0.1% | −322−0.7% | Reduced | Holders |
| Q1 2024 | 43,748 | $1.39M | <0.1% | +43,748 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −81,457−100.0% | Sold out | Holders |
| Q1 2023 | 81,457 | $1.40M | <0.1% | −107,932−57.0% | Reduced | Holders |
| Q4 2022 | 189,389 | $4.21M | <0.1% | +179,345+1,785.6% | Added | Holders |
| Q3 2022 | 10,044 | $81.0K | <0.1% | −15,626−60.9% | Reduced | Holders |
| Q2 2022 | 25,670 | $179.0K | <0.1% | +25,670 | New | Holders |